Clinical Trial Update: Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating allogeneic mesenchymal stem cell transplantation for primary Sjögren's syndrome; the current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Allogeneic mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Sjogren's Syndrome, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: UNKNOWN